Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | PRKCG | P05129 | 1/20 | 0.39 |
| ▸ | PRKCB | P05771 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | PRKCH | P24723 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016025 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9521214 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL7163178 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL15201698 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL7720721 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL15963880 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL6015980 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL8668910 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9521223 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9563973 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729254-B2 | Derivative of glucose and vitamin F, compositions comprising it, uses and preparation process | L'OREAL (FR) | 2014-05-20 | — | — | US | disclosed |
| US-7977318-B2 | Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process | L'OREAL S.A. (FR) | 2011-07-12 | — | — | US | disclosed |
| US-7795230-B2 | Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process | L'OREAL S.A. (FR) | 2010-09-14 | — | — | US | disclosed |
| US-7763587-B2 | Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process | L'OREAL S.A. (FR) | 2010-07-27 | — | — | US | disclosed |
| US-20090149396-A1 | DERIVATIVE OF GLUCOSE AND VITAMIN F, COMPOSITIONS COMPRISING IT, USES AND PREPARATION PROCESS | L'OREAL S.A. | 2009-06-11 | — | — | US | disclosed |
| US-20070123471-A1 | Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process | L'OREAL S.A. | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149396-A1 | DERIVATIVE OF GLUCOSE AND VITAMIN F, COMPOSITIONS COMPRISING IT, USES AND PREPARATION PROCESS | FASN, ELOVL6, FADS2 | PTGS1 3509/4885PTGS2 3073/4885SLC2A1 75/4885 |
| US-20070123471-A1 | Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process | FASN, ELOVL6, ACSL6 | PTGS1 3072/4885PTGS2 2620/4885SLC2A1 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.